Earnings for Oncolytics Biotech (ONCY)

Earnings in 2024 (TTM): -₹2.14 Billion

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -₹2.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2024

Annual earnings

Year	Earnings	Change
2024	-₹2.18 Billion	0.99%
2023	-₹2.15 Billion	23.16%
2022	-₹1.75 Billion	-1.57%
2021	-₹1.78 Billion	9.3%
2020	-₹1.63 Billion	22.2%
2019	-₹1.33 Billion	22.91%
2018	-₹1.09 Billion	3.98%
2017	-₹1.04 Billion	4.75%
2016	-₹1 Billion	8.81%
2015	-₹0.92 Billion	-37.12%
2014	-₹1.45 Billion	-26.12%
2013	-₹1.97 Billion	-37.4%
2012	-₹3.14 Billion	29%
2011	-₹2.43 Billion	46.18%
2010	-₹1.67 Billion	35.46%
2009	-₹1.23 Billion	-14.08%
2008	-₹1.43 Billion	-0.52%
2007	-₹1.44 Billion	24.21%
2006	-₹1.16 Billion	44.52%
2005	-₹0.8 Billion	-11.17%
2004	-₹0.91 Billion	115.42%
2003	-₹0.42 Billion	13.74%
2002	-₹0.37 Billion	-5.45%
2001	-₹0.39 Billion

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Aeterna Zentaris AEZS	-₹0.47 Billion	-78.44%	🇺🇸 USA
Eli Lilly LLY	₹1.082 T	-49,954.14%	🇺🇸 USA
Bristol-Myers Squibb BMY	-₹715.24 Billion	32,842.80%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	-₹24.08 Billion	1,008.71%	🇮🇱 Israel
AVEO Oncology AVEO	-₹2.48 Billion	14.17%	🇺🇸 USA
Mirati Therapeutics MRTX	-₹65.29 Billion	2,907.16%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions